Complete Human Genome Sequence Revealed

The complete human genome sequence of the two X chromosomes and autosomes from the female tissue derived cell line has been completed. This includes the 8% of the genome sequence that was missing in the original draft that was released in 2001. 

The complete human genome sequence of the entire 3.055 billion base pairs has been revealed by the Telomere-to-Telomere (T2T) Consortium. This represents the largest improvement to the human reference genome released in 2001 by Celera Genomics and the International Human Genome Sequencing Consortium. That genome sequence covered most of the euchromatic regions while either leaving out the heterochromatin regions or erroneous representation. These regions comprise 8% of the human genome that has finally been revealed. The new T2T-CHM13 reference1 includes complete sequence for all 22 autosomes plus Chromosome X. This new reference sequence has also corrected numerous errors, and has added approximately 200 million bp of novel sequences containing 2,226 gene copies, out of which 115 are predicted to be protein coding.  

The current GRCh38.p13 reference genome has been as a result of two major updates, one in 2013 and the other one on 2019 on the 2001 Celera genome sequence. However, it still had 151 million base pairs of unknown sequence distributed throughout the genome, including pericentromeric and sub telomeric regions, duplications, gene and ribosomal DNA (rDNA) arrays, all of which are necessary for fundamental cellular processes. The new reference has been named as T2T-CHM13 as it comes from sequencing the DNA from CHM13 (Complete Hydatiform Mole) cell line and is performed by T2T consortium. The cell line is derived from abnormal fertilized egg or an overgrowth of tissue from the placenta in which women appears to be pregnant (false pregnancy), hence the sequence represents only of the two X chromosomes and autosomes of the female. Multiple sequence technologies have been put to use such as PacBio, Oxford Nanopore, 100X and 70X Illumina sequencers to name a few. The technological advances in sequencing have led to the sequencing of the remaining 8% as mentioned above. 

The only limitation of the T2T-CHM13 sequence is the lack of a Y chromosome. This sequencing is currently underway, using the DNA from the HG002 cell line, which has a 46 (23 pairs) with a XY karyotype. The sequence will then be assembled using the same methods developed for the homozygous CHM13 genome. 

The availability of T2T-CHM13 as a new reference genome represents a major breakthrough that will help in understanding the role of heterochromatin regions and help understand its effects on the cellular processes in greater detail. Till the Y chromosome sequencing is completed, this will serve as the reference genome for future studies in understanding the cellular processes and functions. 

***

References 

  1. Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze A V, Mikheenko A et al. The complete sequence of a human genome bioRxiv 2021.05.26.445798; DOI: https://doi.org/10.1101/2021.05.26.445798 

***

Latest

Meteor Produces Daytime Bolide and Sonic Boom Across New England  

A loud sonic boom was heard and a fireball seen around 18:06 UTC Saturday 30...

Carbon-free Ferrocene Analog Synthesised

The synthesis of the first carbon-free inorganic sandwich compound  (an osmium...

Outbreak of Bundibugyo Ebolavirus in DR Congo and Uganda

The current orthoebolavirus outbreak in Democratic Republic of Congo...

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Newsletter

Don't miss

New Colours of ‘Blue Cheese’  

The fungus Penicillium roqueforti is used in the production...

Another COVID-19 Wave Imminent in France: How Many More Yet to Come?

There has been a rapid increase in the delta variant...

MHRA Approves Moderna’s mRNA COVID-19 Vaccine

Medicines and Healthcare products Regulatory Agency (MHRA), the regulator...

‘Fusion Ignition’ demonstrated fourth time at Lawrence Laboratory  

‘Fusion Ignition’ achieved first in December 2022 has been...

Vitamin C and Vitamin E in Diet Reduce Risk of Parkinson’s Disease

Recent research studying almost 44,000 men and women finds...

Nanorobots That Deliver Drugs Directly into The Eyes

For the first time nanorobots have been designed which...
Rajeev Soni
Rajeev Sonihttps://web.archive.org/web/20220523060124/https://www.rajeevsoni.org/publications/
Dr. Rajeev Soni (ORCID ID : 0000-0001-7126-5864) has a Ph.D. in Biotechnology from the University of Cambridge, UK and has 25 years of experience working across the globe in various institutes and multinationals such as The Scripps Research Institute, Novartis, Novozymes, Ranbaxy, Biocon, Biomerieux and as a principal investigator with US Naval Research Lab in drug discovery, molecular diagnostics, protein expression, biologic manufacturing and business development.

Meteor Produces Daytime Bolide and Sonic Boom Across New England  

A loud sonic boom was heard and a fireball seen around 18:06 UTC Saturday 30 May 2026 across New England in the northeastern region of the United States. The bright fireball (bolide) was...

Carbon-free Ferrocene Analog Synthesised

The synthesis of the first carbon-free inorganic sandwich compound  (an osmium ion sandwiched between two boron rings), is a fundamental advancement in chemistry. This was sought by chemists for...

Outbreak of Bundibugyo Ebolavirus in DR Congo and Uganda

The current orthoebolavirus outbreak in Democratic Republic of Congo (DRC) and Uganda is confirmed to be caused by the species Orthoebolavirus bundibugyoense (Bundibugyo virus),...